From: Ambulatory arterial stiffness indices and target organ damage in hypertension
Variables | N = 258 |
---|---|
Age | 53.3 ± 2.0 |
Male, n (%) | 153(59.3) |
Smokers, n (%) | 64(24.8) |
Body mass index, kg/m2 | 27.92 ± 3.83 |
Waist circumference, (cm) | 95.60 ± 11.12 |
Total Cholesterol, (mg/dl) | 208.96 ± 36.94 |
Tryglicerides, (mg/dl) | 126.34 ± 73.35 |
LDL cholesterol, (mg/dl) | 130.64 ± 33.00 |
HDL cholesterol,(mg/dl) | 53.28 ± 3.01 |
Serum creatinine, (mg/dl) | 0.90 ± 0.19 |
Albumin/creatinine (mgg) | 14.65 ± 48.59 |
GFR estimated with CKD-EPI | 88.62 ± 15.41 |
Cornell VDP (mmms) | 1543.89 ± 695.93 |
LVMI (gm2) Novocode | 74.85 ± 18.33 |
Carotid IMT (mm) | 0.71 ± 0.12 |
PWV (m/sec) | 8.65 ± 2.06 |
ABI | 1.08 ± 0.10 |
AASI | 0.37 ± 0.06 |
Awake-AASI | 0.37 ± 0.06 |
Sleep-AASI | 0.38 ± 0.15 |
AASI-BPVR | 0.16 ± 0.16 |
AASI-BPVR-Awake | 0.19 ± 0.20 |
AASI-BPVR-Sleep | 0.08 ± 0.25 |
HASI | 0.59 ± 0.18 |
HASI-BPVR | 0.29 ± 0.24 |
TOD | 94(36.4) |
Renal, n(%) | 37(14.3) |
Vascular, n(%) | 54(20.9) |
Heart, n(%) | 24(9.3) |